散发性包涵体肌炎的免疫芯片分析揭示HLA-DRB1氨基酸异质性
该研究纳入252例来自11个国家的白人IBM患者和1008例族裔匹配对照,用免疫芯片分析免疫相关基因并推算HLA等位基因和氨基酸。结果确认HLA区域关联最强(P=3.58×10^-33),鉴定出HLA-DRB1*03:01、DRB1*01:01和DRB1*13:01三个独立关联,最强关联位于HLA-DRB1分子第26和11位氨基酸。这些氨基酸关联可将IBM与多发性肌炎和皮肌炎区分,并提示染色体3p21.31区域CCR5可能参与。
要点
- HLA是IBM关联最强的区域,最强信号位于HLA-DRB1第26和11位氨基酸。
- 鉴定出HLA-DRB1*03:01、DRB1*01:01和DRB1*13:01三个独立关联。
- HLA-DRB1氨基酸关联可将IBM与多发性肌炎和皮肌炎区分。
核心结论
- HLA是IBM关联最强的区域,HLA-DRB1第26和11位氨基酸关联可能解释该位点风险。
- 这些氨基酸关联可将IBM与多发性肌炎和皮肌炎区分,并可能影响肽结合槽特性。
- 染色体3p21.31区域提示CCR5在IBM中可能发挥作用。
研究设计与样本
- 纳入252例来自11个国家的白人IBM患者,与1008例族裔匹配对照比较。
- 使用免疫芯片分析免疫相关基因,并用SNP2HLA推算经典HLA等位基因和氨基酸。
主要发现
- HLA区域关联最强,P=3.58×10^-33。
- HLA推算鉴定出HLA-DRB1*03:01、DRB1*01:01和DRB1*13:01三个独立关联。
- 最强关联位于HLA-DRB1分子第26和11位氨基酸。
- 未发现独立于HLA-DRB1*03:01的抗胞质5'-核苷酸酶1A阳性状态关联。
- HLA基因型与IBM发病年龄无关联,三个非HLA区域达提示性显著,包括染色体3p21.31。
关键数值与推荐
- HLA区域关联P=3.58×10^-33。
- 三个独立HLA关联为HLA-DRB1*03:01、DRB1*01:01和DRB1*13:01。
- 最强氨基酸关联位于HLA-DRB1第26和11位。
- 染色体3p21.31区域达提示性显著,CCR5移码突变被认为是可能因果变异。
临床怎么用
- HLA-DRB1氨基酸关联有助于在科研层面区分IBM与多发性肌炎和皮肌炎。
- 抗胞质5'-核苷酸酶1A阳性状态与HLA的关联需结合HLA-DRB1*03:01解读。
- HLA基因型未显示与IBM发病年龄相关,不宜用于发病年龄预测。
局限性
- 非HLA区域仅达提示性显著,染色体3p21.31和CCR5的作用需进一步验证。
- 研究人群为白人IBM患者,结论外推至其他族裔需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Inclusion body myositis (IBM) is characterized by a combination of inflammatory and degenerative changes affecting muscle. While the primary cause of IBM is unknown, genetic factors may influence disease susceptibility. To determine genetic factors contributing to the etiology of IBM, we conducted the largest genetic association study of the disease to date, investigating immune-related genes using the Immunochip. METHODS: A total of 252 Caucasian patients with IBM were recruited from 11 countries through the Myositis Genetics Consortium and compared with 1,008 ethnically matched controls. Classic HLA alleles and amino acids were imputed using SNP2HLA. RESULTS: The HLA region was confirmed as the most strongly associated region in IBM (P = 3.58 × 10-33 ). HLA imputation identified 3 independent associations (with HLA-DRB1*03:01, DRB1*01:01, and DRB1*13:01), although the strongest association was with amino acid positions 26 and 11 of the HLA-DRB1 molecule. No association with anti-cytosolic 5'-nucleotidase 1A-positive status was found independent of HLA-DRB1*03:01. There was no association of HLA genotypes with age at onset of IBM. Three non-HLA regions reached suggestive significance, including the chromosome 3 p21.31 region, an established risk locus for autoimmune disease, where a frameshift mutation in CCR5 is thought to be the causal variant. CONCLUSION: This is the largest, most comprehensive genetic association study to date in IBM. The data confirm that HLA is the most strongly associated region and identifies novel amino acid associations that may explain the risk in this locus. These amino acid associations differentiate IBM from polymyositis and dermatomyositis and may determine properties of the peptide-binding groove, allowing it to preferentially bind autoantigenic peptides. A novel suggestive association within the chromosome 3 p21.31 region suggests a role for CCR5.
引用
- Rothwell S, Cooper RG, Lundberg IE, et al. Immune-Array Analysis in Sporadic Inclusion Body Myositis Reveals HLA-DRB1 Amino Acid Heterogeneity Across the Myositis Spectrum. Arthritis Rheumatol. 2017. PMID: 28086002. doi:10.1002/art.40045
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。